8/28/2014 - 9:48 AM EST - Miraculins Inc. : announced its plans to file pre-submission documentation with the United States Food and Drug Administration (USFDA) regarding the de novo classification of its Scout DS® device, as a next step in securing marketing clearance in the United States. Miraculins Inc.
shares V.MOM are trading up $0.01 at $0.29.
